Cargando…

Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India

In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheth, Jay U, Narayanan, Raja, Anantharaman, Giridhar, Bhende, Muna, Agarwal, Aniruddha, Chawla, Shobhit, Rajendran, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672796/
https://www.ncbi.nlm.nih.gov/pubmed/35918981
http://dx.doi.org/10.4103/ijo.IJO_2985_21
_version_ 1784832819559661568
author Sheth, Jay U
Narayanan, Raja
Anantharaman, Giridhar
Bhende, Muna
Agarwal, Aniruddha
Chawla, Shobhit
Rajendran, Anand
author_facet Sheth, Jay U
Narayanan, Raja
Anantharaman, Giridhar
Bhende, Muna
Agarwal, Aniruddha
Chawla, Shobhit
Rajendran, Anand
author_sort Sheth, Jay U
collection PubMed
description In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV evolves, retinal physicians must constantly modify their current practice. The current guidelines are based on the most up-to-date information on PCV and are an update to the previous set of guidelines. These guidelines were developed by a panel of Indian retinal experts under the aegis of the Vitreoretinal Society of India (VRSI), based on a comprehensive search and assessment of literature up to September 2021. The final guidelines i) provide the updated nomenclature in PCV; ii) discusses the newer diagnostic imaging features of PCV, especially in the absence of indocyanine green angiography (ICGA); and iii) recommends the best possible therapeutic approach in the management of PCV, including the choice of anti-vascular endothelial growth factor (anti-VEGF) agents, treatment regimen, and the role of switching between the anti-VEGF agents. In the face of non-availability of photodynamic therapy (PDT) in India, we constructed practical recommendations on anti-VEGF monotherapy in PCV. The current updated recommendations would provide a broader framework to the treating retinal physician for the diagnosis and management of PCV for optimal therapeutic outcomes.
format Online
Article
Text
id pubmed-9672796
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-96727962022-11-19 Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India Sheth, Jay U Narayanan, Raja Anantharaman, Giridhar Bhende, Muna Agarwal, Aniruddha Chawla, Shobhit Rajendran, Anand Indian J Ophthalmol Consensus Criteria In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV evolves, retinal physicians must constantly modify their current practice. The current guidelines are based on the most up-to-date information on PCV and are an update to the previous set of guidelines. These guidelines were developed by a panel of Indian retinal experts under the aegis of the Vitreoretinal Society of India (VRSI), based on a comprehensive search and assessment of literature up to September 2021. The final guidelines i) provide the updated nomenclature in PCV; ii) discusses the newer diagnostic imaging features of PCV, especially in the absence of indocyanine green angiography (ICGA); and iii) recommends the best possible therapeutic approach in the management of PCV, including the choice of anti-vascular endothelial growth factor (anti-VEGF) agents, treatment regimen, and the role of switching between the anti-VEGF agents. In the face of non-availability of photodynamic therapy (PDT) in India, we constructed practical recommendations on anti-VEGF monotherapy in PCV. The current updated recommendations would provide a broader framework to the treating retinal physician for the diagnosis and management of PCV for optimal therapeutic outcomes. Wolters Kluwer - Medknow 2022-08 2022-07-29 /pmc/articles/PMC9672796/ /pubmed/35918981 http://dx.doi.org/10.4103/ijo.IJO_2985_21 Text en Copyright: © 2022 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Consensus Criteria
Sheth, Jay U
Narayanan, Raja
Anantharaman, Giridhar
Bhende, Muna
Agarwal, Aniruddha
Chawla, Shobhit
Rajendran, Anand
Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
title Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
title_full Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
title_fullStr Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
title_full_unstemmed Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
title_short Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
title_sort updated guidelines for the management of polypoidal choroidal vasculopathy: recommendations from the indian polypoidal choroidal vasculopathy panel and the vitreoretinal society of india
topic Consensus Criteria
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672796/
https://www.ncbi.nlm.nih.gov/pubmed/35918981
http://dx.doi.org/10.4103/ijo.IJO_2985_21
work_keys_str_mv AT shethjayu updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia
AT narayananraja updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia
AT anantharamangiridhar updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia
AT bhendemuna updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia
AT agarwalaniruddha updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia
AT chawlashobhit updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia
AT rajendrananand updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia